Report: LDT market to exceed $17B
October 20, 2020 -- A new report from Kalorama Information estimates the market for laboratory-developed tests (LDTs) is currently valued at $12 billion, and this figure will grow to $17 billion by 2025. The COVID-19 pandemic is driving demand for new LDTs, even as regulatory agencies duel over how to regulate the tests  Discuss
NIH, BARDA award $98.35M in COVID-19 testing contracts
October 7, 2020 -- The U.S. National Institutes of Health (NIH), along with the Biomedical Advanced Research and Development Authority (BARDA), a U.S. federal health agency, has awarded $98.35 million in contracts for COVID-19 testing under the Rapid Acceleration of Diagnostics initiative.
Quidel gets EUA for combo flu, COVID-19 test
October 6, 2020 -- Quidel has received a U.S. Food and Drug Administration emergency use authorization (EUA) for a rapid diagnostic that can simultaneously identify influenza A, influenza B, and the novel coronavirus.
LabCorp nabs EUA for new COVID-19 molecular test
October 5, 2020 -- The U.S. Food and Drug Administration has awarded LabCorp emergency use authorization (EUA) for a new, high-throughput method that uses heat and technology to extract RNA from COVID-19 samples.
Rover's rapid COVID-19 test advances to phase I of RADx
October 2, 2020 -- The U.S. National Institutes of Health has selected a COVID-19 rapid test from Rover Diagnostics and Columbia Engineering for phase I of the Rapid Acceleration of Diagnostics (RADx) initiative.
Urgent care centers earn over $400M from COVID-19 testing
October 1, 2020 -- With approximately 10,000 urgent care locations across the country and more than three-fourths of the U.S. population residing within a 10-minute drive of one, the urgent care market is expected to grow, writes Bruce Carlson of Kalorama Information, a sister company of LabPulse.com.  Discuss
Quadrant wins EUA for COVID-19 saliva test
September 24, 2020 -- Quadrant Biosciences has received emergency use authorization (EUA) from the U.S. Food and Drug Administration for its Clarifi COVID-19 test kit.
BD seeks FDA OK to use more samples with HPV test
September 23, 2020 -- Becton Dickinson (BD) has asked the U.S. Food and Drug Administration (FDA) to make the ThinPrep Pap Test PreservCyt solution vial an approved sample for its Onclarity HPV assay.
Hoth, GW partner to develop mobile COVID-19 test
September 21, 2020 -- Clinical-stage biopharmaceutical company Hoth Therapeutics and George Washington University (GW) have partnered to create a device that allows health professionals to diagnose COVID-19 with a mobile device.
Rapid point-of-care COVID-19 test shows promise in clinical study
September 18, 2020 -- A rapid COVID-19 test that can produce results at the point of care in just 90 minutes without sending samples to a central lab has demonstrated 94% sensitivity and 100% specificity, according to a new study published in the Lancet Microbe.  Discuss